Amparo Ruı́z

4.0k total citations
51 papers, 2.2k citations indexed

About

Amparo Ruı́z is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Amparo Ruı́z has authored 51 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Cancer Research, 20 papers in Oncology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Amparo Ruı́z's work include Breast Cancer Treatment Studies (22 papers), HER2/EGFR in Cancer Research (10 papers) and Cancer Treatment and Pharmacology (9 papers). Amparo Ruı́z is often cited by papers focused on Breast Cancer Treatment Studies (22 papers), HER2/EGFR in Cancer Research (10 papers) and Cancer Treatment and Pharmacology (9 papers). Amparo Ruı́z collaborates with scholars based in Spain, United States and Germany. Amparo Ruı́z's co-authors include António Pellicer, Ana Cobo, J. Remohı́, Sonia Pérez, Vicente Guillém, Miguel Martín, Aňa Lluch, José Remohı́, Federico Rojo and Pere Gascón and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and The Lancet Oncology.

In The Last Decade

Amparo Ruı́z

51 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amparo Ruı́z Spain	21	823	626	618	558	499	51	2.2k
Florian Clatot France	24	692 0.8×	218 0.3×	165 0.3×	461 0.8×	321 0.6×	99	1.6k
Tsui-Lien Mao Taiwan	25	574 0.7×	229 0.4×	1.4k 2.3×	654 1.2×	2.0k 4.1×	31	3.2k
Bojana Djordjevic Canada	25	314 0.4×	92 0.1×	672 1.1×	392 0.7×	679 1.4×	57	1.9k
Patricia A. Shaw Canada	29	1.1k 1.3×	280 0.4×	1.4k 2.3×	623 1.1×	976 2.0×	57	3.0k
Virginia L. Filiaci United States	26	505 0.6×	210 0.3×	2.1k 3.3×	214 0.4×	461 0.9×	49	3.4k
Shoji Kodama Japan	20	806 1.0×	218 0.3×	1.5k 2.4×	233 0.4×	474 0.9×	40	2.6k
Arto Leminen Finland	28	538 0.7×	123 0.2×	590 1.0×	293 0.5×	415 0.8×	60	1.9k
Olivier Caron France	23	842 1.0×	96 0.2×	100 0.2×	657 1.2×	1.0k 2.1×	72	2.4k
Siranoush Manoukian Italy	26	637 0.8×	256 0.4×	444 0.7×	798 1.4×	992 2.0×	81	2.6k
A. Berchuck United States	21	337 0.4×	126 0.2×	673 1.1×	224 0.4×	417 0.8×	42	1.4k

Countries citing papers authored by Amparo Ruı́z

Since Specialization

Citations

This map shows the geographic impact of Amparo Ruı́z's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amparo Ruı́z with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amparo Ruı́z more than expected).

Fields of papers citing papers by Amparo Ruı́z

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amparo Ruı́z. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amparo Ruı́z. The network helps show where Amparo Ruı́z may publish in the future.

Co-authorship network of co-authors of Amparo Ruı́z

This figure shows the co-authorship network connecting the top 25 collaborators of Amparo Ruı́z. A scholar is included among the top collaborators of Amparo Ruı́z based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amparo Ruı́z. Amparo Ruı́z is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Šestak, Ivana, Miguel Martín, Peter Dubsky, et al.. (2019). Prediction of chemotherapy benefit by EndoPredict in patients with breast cancer who received adjuvant endocrine therapy plus chemotherapy or endocrine therapy alone. Breast Cancer Research and Treatment. 176(2). 377–386. 57 indexed citations

Camp, Nicola J., Jesús Herránz, Álvaro Rodríguez-Lescure, et al.. (2019). Re-interpretation of PAM50 gene expression as quantitative tumor dimensions shows utility for clinical trials: application to prognosis and response to paclitaxel in breast cancer. Breast Cancer Research and Treatment. 175(1). 129–139. 8 indexed citations

Murray, Nigel P, et al.. (2015). Diagnostic Yield of Primary Circulating Tumor Cells in Women Suspected of Breast Cancer: the BEST (Breast Early Screening Test) Study. Asian Pacific Journal of Cancer Prevention. 16(5). 1929–1934. 13 indexed citations

Garrido, Nicolás, Ernesto Bosch, Pilar Alamá, & Amparo Ruı́z. (2015). The time to prevent mendelian genetic diseases from donated or own gametes has come. Fertility and Sterility. 104(4). 833–835. 1 indexed citations

Martín, Miguel, Jan C. Brase, Lourdes Calvo, et al.. (2014). Clinical validation of the EndoPredict test in node-positive, chemotherapy-treated ER+/HER2− breast cancer patients: results from the GEICAM 9906 trial. Breast Cancer Research. 16(2). R38–R38. 107 indexed citations

Bermejo, Begoña, Amparo Ruı́z, Manuel Ruíz Borrego, et al.. (2013). Randomized phase III study of adjuvant chemotherapy for node-positive early breast cancer (BC) patients (pts) comparing epirubicin plus cyclophosphamide followed by docetaxel (EC-T) versus epirubicin plus docetaxel followed by capecitabine (ET-X): Efficacy analysis of the GEICAM/2003-10 trial.. Journal of Clinical Oncology. 31(15_suppl). 1027–1027. 2 indexed citations

Llombart‐Cussac, Antonio, Ángel Guerrero, António Galán de Mera, et al.. (2012). Phase II trial with letrozole to maximum response as primary systemic therapy in postmenopausal patients with ER/PgR[+] operable breast cancer. Clinical & Translational Oncology. 14(2). 125–131. 46 indexed citations

Puente, Javier, Sara López‐Tarruella, Amparo Ruı́z, et al.. (2010). Practical prognostic index for patients with metastatic recurrent breast cancer: retrospective analysis of 2,322 patients from the GEICAM Spanish El Alamo Register. Breast Cancer Research and Treatment. 122(2). 591–600. 36 indexed citations

Castel, Victoria, Eva Villamón, Adela Cañete, et al.. (2010). Neuroblastoma in adolescents: genetic and clinical characterisation. Clinical & Translational Oncology. 12(1). 49–54. 30 indexed citations

10.

Alba, Emilio, Manuel Ruíz‐Borrego, Mireia Margelí Vila, et al.. (2010). Maintenance treatment with Pegylated liposomal doxorubicin versus observation following induction chemotherapy for metastatic breast cancer: GEICAM 2001-01 study. Breast Cancer Research and Treatment. 122(1). 169–176. 58 indexed citations

11.

Cobo, Ana, et al.. (2007). Comparison of concomitant outcome achieved with fresh and cryopreserved donor oocytes vitrified by the Cryotop method. Fertility and Sterility. 89(6). 1657–1664. 398 indexed citations

12.

Martín, Miguel, Amparo Ruı́z, A. Balil, et al.. (2007). Gemcitabine plus vinorelbine versus vinorelbine monotherapy in patients with metastatic breast cancer previously treated with anthracyclines and taxanes: final results of the phase III Spanish Breast Cancer Research Group (GEICAM) trial. The Lancet Oncology. 8(3). 219–225. 139 indexed citations

13.

Burgués, Octavio, Samuel Navarro, Rosa Noguera, et al.. (2006). Prognostic value of the International Neuroblastoma Pathology Classification in Neuroblastoma (Schwannian stroma-poor) and comparison with other prognostic factors: a study of 182 cases from the Spanish Neuroblastoma Registry. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 449(4). 410–420. 27 indexed citations

14.

Gómez, Raúl, et al.. (2006). Plasma levels of soluble vascular endothelial growth factor receptor-1 may determine the onset of early and late ovarian hyperstimulation syndrome. Human Reproduction. 21(6). 1453–1460. 46 indexed citations

15.

Pehlivan, Tugce, Carmen Rubio, Amparo Ruı́z, et al.. (2004). Embryonic Chromosomal Abnormalities Obtained After Rescue Intracytoplasmic Sperm Injection of 1-Day-Old Unfertilized Oocytes. Journal of Assisted Reproduction and Genetics. 21(2). 55–57. 19 indexed citations

16.

Ruı́z, Amparo, et al.. (2002). Ductal Carcinoma In Situ of the Breast: A Comparative Analysis of Histology, Nuclear Area, Ploidy, and Neovascularization Provides Differentiation Between Low- and High-Grade Tumors. The Breast Journal. 8(3). 139–144. 11 indexed citations

17.

Cobo, Ana, Carmen Rubio, Sandro Gerli, et al.. (2001). Use of fluorescence in situ hybridization to assess the chromosomal status of embryos obtained from cryopreserved oocytes. Fertility and Sterility. 75(2). 354–360. 105 indexed citations

18.

Ruı́z, Amparo, Sergio Almenar, Robert C. Callaghan, & Antonio Llombart‐Bosch. (1999). Benign, Preinvasive and Invasive Ductal Breast Lesions. A Comparative Study with Quantitative Techniques: Morphometry, Image- and Flow Cytometry. Pathology - Research and Practice. 195(11). 741–746. 12 indexed citations

19.

Bolufer, Pascual, Aňa Lluch, Eva Barragán, et al.. (1997). Prognostic significance of c-erbB-2/neu amplification and epidermal growth factor receptor (EGFR) in primary breast cancer and theor relation to estradiol receptor (ER) status. Clinica Chimica Acta. 262(1-2). 99–119. 36 indexed citations

20.

Tarı́n, Juan J., Amparo Ruı́z, F. Miró, Fernando Bonilla‐Musoles, & António Pellicer. (1991). Failed in vitro fertilization of human oocytes: a cytogenetic analysis. Fertility and Sterility. 56(2). 290–295. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact